含5—氟尿嘧啶生物可降解聚磷酰胺的合成及其抗肿瘤活性研究

通过Ｌ－赖氨酸（Ｎ＾１－５－氟尿嘧啶）烷基酯双盐酸盐与二氯磷酸乙酯，二氯膦甲酸乙酯，二氯膦乙酸乙酯共聚，合成了三类１２种侧链含５－氟尿嘧啶的聚磷酰胺。聚合物的结构经ＵＶ，ＩＲ，ＨＮＭＲ及元纱分析鉴定。聚合物用微量细胞培养四氮唑实验方法（ＭＴＴ法）进行了对人肝癌细胞系Ｂｅｌ－７４０２细胞的微量培养实验。     

主链含氨基酸、5-氟尿嘧啶和膦甲酸乙酯(膦乙酸乙酯)的聚磷酰胺和聚磷酸酯的合成及抗肿瘤活性研究

由1,3-双(氨基酸丙酯盐酸盐)-5-氟尿嘧啶与膦甲(乙)酸乙酯在DMF中反应制得二十种主链含氨基酸、膦甲(乙)酸乙酯和5-氟尿嘧啶三组分的聚合物。通过核磁、红外和紫外光谱以及元素分析测定了聚合物的结构。并试验了聚合物的体外抗肿瘤活性。     

含嘧啶碱基和膦甲酸乙酯的聚磷酸酯的合成及其抗肿瘤活性

本文通过十一种二羟基嘧啶衍生物单体与P,P-二氯膦甲酸乙酯进行缩聚反应,合成了十一种新的含5-氟脲嘧啶、尿嘧啶、胸腺嘧啶和膦甲酸乙酯的聚磷酸酯。用核磁、红外光谱及元素分析确定了聚合物的结构。进行了部分聚合物抗动物肿瘤活性试验,含5-氟脲嘧啶和膦甲酸乙酯的聚磷酯对小鼠艾氏腹水癌的抑制率可达56％。     

二氯甲基膦酸二乙酯与醛、酮的反应——1,1-二氯代烯烃的制备

本文报导了以二氯甲基膦酸二乙酯作试剂,在正丁基锂作用下与醛、酮化合物反应制备1,1-二氯代烯烃的合成方法。该试剂在相近条件下与醛、酮反应无显著差别,均得到了较满意的结果。二氯甲基膦酸二乙酯由络合物[Cl₂CHPCl₃]⁺AlCl₄^-与无水乙醇反应制得。     

主链含氨基酸、5-氟尿嘧啶、氮芥的聚磷酰胺和聚磷酸酯的合成及其抗肿瘤活性研究

由1,3-双(氨基酸丙酯盐酸盐)-5-氟尿嘧啶与双(2-氯乙基)氨基磷酰二氯在DMF中反应得到十种含氨基酸、氮芥和5-氟尿嘧啶啶三组分的聚合物。通过核磁、红外和紫外以及元素分析测定了聚合物的结构。试验了聚合物的体外抗肿瘤活性。     

可生物降解聚[(对羟基苯甲酸甲酯/甘氨酸乙酯)膦腈]的合成及其体外降解

以PCl5和NH4Cl为原料,利用一锅法制备了聚二氯膦腈,通过两步亲核取代反应,分别以甘氨酸乙酯和对羟基苯甲酸甲酯为亲核试剂,合成了混合取代可生物降解聚[(对羟基苯甲酸甲酯/甘氨酸乙酯)膦腈].用核磁共振波谱及红外光谱等对产物结构进行了表征.研究了甘氨酸乙酯和对羟基苯甲酸甲酯的比例及外界环境对所制备的聚膦腈降解性能的影响,并进行了体外降解实验.研究结果表明,通过改变甘氨酸乙酯和对羟基苯甲酸甲酯的比例,可获得一种降解速率可调节的生物降解膦腈聚合物.     

1-苯基-3-甲基-4-二氯乙酰基吡唑酮-5和三正辛基氧化膦协同萃取镧系离子的研究

1-苯基-3-甲基-4-三氟乙酰基吡唑酮-5(PMTFP)与磷酸三丁酯(TBP)或三正辛基氧化膦(TOPO)对三价稀土的协同萃取已有报道^[1,2]。本文研究了1-苯基-3-甲基-4-二氯乙酰基吡唑酮-5(PMDCP)和TOPO的氯仿溶液从硝酸介质中对La³⁺、Nd³⁺、Dy³⁺和Yb³⁺的协同萃取。     

主链含膦酸酯的聚酸酐药物控制释放材料研究

通过二氯膦甲（乙）酸乙酯与对羟乙氧基苯甲酸反应，制备了二羧苯氧乙氧基膦甲（乙）酸乙酯，并其转化成混合醋酐并通过熔融缩聚，合成了主链含膦甲（乙）酸乙酯的聚酸酐，以二羧苯氧乙氧基膦甲（乙）酸乙酯，分别与１，３－双（４－羧基苯氧基）丙烷（ＣＰＰ）及癸二酸（ＳＡ）共聚，得到相应的共聚酸酐，对所合成的单体和聚合物的结构进行了表征，研究了它们的体外降解，酶促降解及其对抗肿瘤药物５－氟尿嘧啶和氨甲喋蛉的释放性能     

具有新型梯形双金属链的铕羧酸-膦酸配合物的晶体结构及其发光性质研究

采用溶剂热反应,成功合成一例基于羧酸-膦酸配体的铕配位聚合物,[Eu(5-pnc)(H₂O)_0.5]·H₂O(1)。晶体结构分析表明,聚合物1具有三维超分子网络结构,其中二聚体[Eu₂(μ3-O)₂]通过两个O-P-O和两个O-C-O单元构成梯形双金属链,沿着a轴无限延伸,这些梯形双金属链通过有机膦酸配体交联。研究了配位聚合物1的热稳定性、紫外可见光谱和发光性能。     

聚5-氟尿嘧啶-1-乙酰天冬氨酰二胺的合成及其抗肿瘤活性

本文报道5-氟尿嘧啶-1-乙酰天冬氨酸,5-氟尿嘧啶-1-乙酰天冬氨酸双对硝基苯酯的合成。并用5-氟尿嘧啶-1-乙酰天冬氨酸双对硝基苯酯与一系列α,ω-二胺或赖氨酸乙酯缩聚,合成了五个聚5-氟尿嘧啶-1-乙酰天冬氨酰二胺和一个聚5-氟尿嘧啶-1-乙酰天冬氨酰赖氨酸乙酯。用~1HNMR,IR,UV和元素分析表征和签定了所得的单体和聚合物。抗动物肿瘤试验结果表明:聚5-氟尿嘧啶-1-乙酰天冬氨酰戊二胺,聚5-氟尿嘧啶-1-乙酰天冬氨酰赖氨酸乙酯,对小鼠艾氏腹水癌的抑制率分别为31.85％,44.23％。     

Synthesis and Properties of Hydrophilic Copolymers Containing 5-Fluorouracil,Thymine, or Adenine

Hydrophilic copolymers containing 5-fluorouracil (5-FU), thymine, or adenine were prepared by the free-radical copolymerization of methacryloyl-type monomers containing them with water-soluble vinyl monomers such as acrylic acid, methacrylic acid, vinylpyrroli-done, acrylamide, and 4(5)-vinylimidazole with AIBN as initiator. Complex formation between the copolymers and RNA and between the copolymers having complementary nucleic acid bases in aqueous solution and a DMSO-ethylene glycol was studied by means of UV spectroscopy. These copolymers were found to release the N-hydroxyethyl derivatives of 5-FU, thymine, or adenine by hydrolysis of the ester of the polymer side chain under mild conditions. The effects of the kind of water-soluble comonomer, temperature, pH, and the imidazole group as catalyst on the hydrolysis of the ester are discussed.     

Ring closure reaction of 4-(2-hydroxyanilino)-2-phenyl-5-pyrimidinecarboxylic acid with acetic anhydride. Synthesis of pyrimido[5,4-c] [1,5]benzoxazepin-5(11H)ones

Syntheses of 11-acety1-2-phenylpyrimido[5,4-c][1,5]benzoxazepin-5(11H)one ( 16a ) and analogs ( 16b,c, 22 ) were described. The reaction of 4-chloro-2-phenyl-5-pyrimidinecarboxylic acid ethyl ester ( 7 ) with 2-aminophenol afforded 4-(2-hydroxyanilino)-2-phenyl-5-pyrimidine-carboxylic acid ethyl ester ( 8a ). The latter was also prepared by catalytic reduction of 4-(2-nitrophenoxy)-2-phenyl-5-pyrimidinecarboxylic acid ethyl ester ( 9 ), which was obtained from 7 and 2-nitrophenol. Involvement of 4-(2-aminophenoxy)-2-phenyl-5-pyrimidinecarboxylic acid ethyl ester ( 12a ) in this reduction as an intermediate was demonstrated by an independent synthesis of 12a and its subsequent rearrangement to 8a. Hydrolysis of 8a or 12a gave 4-(2-hydroxyanilino)-2-phenyl-5-pyrimidinecarboxylic acid ( 15a ). Reaction of 15a with acetic anhydride afforded 16a , the first member of a novel ring system, the pyrimido[5,4- c ][1,5]-benzoxazepin. Additional examples ( 16b,c ) were prepared similarly. The corresponding 11-ethyl derivative ( 22 ) was prepared in similar fashion, starting with 7 and 2-ethylaminophenol. A possible reaction mechanism for the formation of 16a-c from 15a-c and acetic anhydride was discussed.     

3-(2-氧代环烷基)丙酸与(R)-2-硫代四氢噻唑-4-羧酸乙酯的反应

３－（２－氧代环烷基）丙酸与（Ｒ）－２－硫代四氢噻唑－４－羧酸乙酯的反应李叶芝,田颜清,黄化民（吉林大学化学,长春,１３００２３）关键词（Ｒ）－２－硫代四氢噻唑－４－羧酸乙酯,Ｎ－３－（２－氧代环烷基）丙酰－２－硫代四氢噻唑－４－羧酸乙酯,环合反应,...     

Rearrangements of 4-(2-Aminophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester

The treatment of 4-(2-aminophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylic acid diethyl ester (III) with refluxing toluene or pyridine afforded 1,2,3,6-tetrahydro-2,4-dimethyl-2,6-methano-1,3-benzodiazocine-5,11-dicarboxylic acid diethyl ester (IV) as the major product. In addition, the following minor products were isolated: 2-methyl-3-quinolinecarboxylic acid ethyl ester (V), 3-(2-aminophenyl)-5-methyl-6-azabicyclo[3,3,1]-hept-1-ene-2,4-dicarboxylic acid diethyl ester (VI), and 5,6-dihydro-2,4-dimethyl-5-oxobenzo[c][2,7]naphthyridine-1-carboxylic acid ethyl ester (VII). In contrast, acidic conditions caused the conversion of III into V in a 95% yield. The formation of the latter appears to involve IV as an intermediate, since IV degraded rapidly in acid to give V in a quantitative yield.     

N-(5-氯-2-羟苯基)氨基酸酯的合成、表征及抑菌活性

以5-Cl水杨醛和L-苯丙氨酸、L-亮氨酸及L-甘氨酸的脂肪酸酯为原料,通过碱催化的席夫碱缩合反应,合成了6种N-（5-氯-2-羟苄基）席夫碱氨基酸酯及其还原产物N-（5-氯-2-羟苄基）氨基酸酯。 化合物的结构及组成经过IR、¹H NMR和元素分析测试技术进行了表征。 合成的席夫碱及其还原产物对革兰氏阴性菌、革兰氏阳性菌及真菌均有不同程度的抑制作用。 质量分数为0.01%的N-（5-氯-2-羟苄基）席夫碱氨基酸酯对大肠杆菌的抑菌率达90%以上,而N-（5-氯-2-羟苄基）氨基酸酯对金黄色葡萄球菌的抑菌率也在90%以上,均为强抑菌活性,其中N-（5-氯-2-羟苄基）苯丙氨酸酯的抑菌率达98%以上。     

Selection of Planar Chiral Conformations between Pillar[5,6]arenes Induced by Amino Acid Derivatives in Aqueous Media

Chiral α-amino acids play critical roles in the metabolic process in nearly all life forms. So far, chiral recognition of α-amino acids has mainly focused on the determination of l /d enantiomers. Herein, selection of planar chiral conformations between water-soluble pillar[5]arene WP5 and pillar[6]arene WP6 was observed due to α-side chain or ethyl ester moieties of l -α-amino acid ethyl ester hydrochlorides binding with WP5 and WP6 , respectively. Therefore, α-side chain and ethyl ester moieties of l -α-amino acid ethyl ester hydrochlorides were recognized by observing the induced CD signal and its inversion. This is a rare example of being able to detect the chiral region around α-carbon of a chiral α-amino acid molecule.     

热分离进样/气相色谱-质谱法测定橄榄油中脂肪酸乙酯

建立了热分离进样/气相色谱-质谱快速测定橄榄油中4种脂肪酸乙酯(棕榈酸乙酯、硬脂酸乙酯、油酸乙酯、亚油酸乙酯)的分析方法。采用热分离进样技术进样,以DB-5MS色谱柱分离,选择离子监测模式检测。结果显示,4种脂肪酸乙酯在0.01～0.20 mg/L范围内线性良好(r~20.999),方法的检出限(LOD)和定量下限(LOQ)分别为0.3 mg/kg和1.0 mg/kg,在低、中、高3个加标水平(1.0、2.0、10 mg/kg)下的回收率为82.4%～109%,相对标准偏差(RSD)为0.68%～6.8%。该方法灵敏度高,准确度和重现性好,可用于橄榄油中4种脂肪酸乙酯的快速检测。     

Synthesis and Antimicrobial Activity of Substituted 5-Cyano-6-oxo-2-styrylnicotinic Acids

Derivatives of the anilide or ethyl ester of 5-cyano-6-oxo-2-styrylnicotinic acid are formed in the reaction of the anilide or ethyl ester of 5-cyano-2-methyl-6-oxonicotinic acid with aromatic aldehydes. On interaction with hydrazine hydrate the products are converted into hydrazides of 5-cyano-6-oxo-2-styrylnicotinic acid derivatives.     

Synthesis and single cell pharmacology of potential heterocyclic bioisosteres of the excitatory amino acid antagonist glutamic acid diethyl ester

A series of heterocyclic analogues of glutamic acid diethyl ester (GDEE), an antagonist at central excitatory amino acid receptors, have been synthesized and tested biologically. (RS)-Ethyl alpha-amino-alpha-(3-ethoxyisoxazol-5-yl)acetate (7), (RS)-ethyl 2-amino-3-(3-ethoxy-5-methylisoxazol-4-yl)propionate (16) and closely related analogues were synthesized. Compound 7, a diethyl derivative of the naturally occurring excitatory amino acid ibotenic acid (IBO), was synthesized from 3-hydroxy-5-methylisoxazole (1) via 3-ethoxyisoxazol-5-ylacetic acid (5) and its ethyl ester. Nitrosation of this ester followed by catalytic reduction gave 7. The ethyl ester of IBO, 9, was synthesized in a similar manner from 3-benzyloxyisoxazol-5-ylacetic acid (8). Ethyl derivatives of the synthetic excitatory amino acid 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) were synthesized from 3-hydroxy-4,5-dimethylisoxazole (10) through a diethyl acetylaminomalonate derivative, which upon deprotection gave the 3-ethoxy derivative of AMPA (15). Esterification of 15 gave the diethyl derivative 16 and the ethyl ester of AMPA (18) as well as N-ethylated derivatives of AMPA, 21 and 22 were synthesized. The final products were tested microelectrophoretically. The derivatives 7, 9, 15, 16 and 18 were weak and non-selective excitatory amino acid antagonists, whereas 21 and 22 were found to be inactive.     

Thiazolecarboxylic Acid Derivatives. 1. N-Substituted 2-Amino-4-methylthiazole-5-carboxylic Acid Derivatives

Acylation of the ethyl ester and anilide of 2-amino-4-methylthiazole-5-carboxylic acid gave 2-acetyl(arylsulfonyl)amino derivatives. Methylation of acetylaminothiazole and subsequent deacetylation gave 2-methylamino-4-methylthiazole-5-carboxylic acid, which was then converted into esters. The ethyl ester and anilide of thiazole-2-carboxylic acid were used as starting compounds for the synthesis of 2-dimethylaminoformimino- and 2-chlorobenzenesulfonylureido derivatives.